Qualia Clinical Services chooses ALPHADAS for Phase I Clinical Trials
October 22nd 2008Qualia Clinical Services, a division of Holmes Biopharma, selects ALPHADAS, Logos Technologies electronic data capture (EDC) system to streamline and automate clinical trials in its Phase I clinical facility in Omaha, Nebraska.
Pharsight Initiates Beta Testing of New Advanced Platform for Modeling Software Products
October 21st 2008Pharsight Corporation, a provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that is has initiated beta testing of its new Phoenix analysis and modeling software platform.
PharmaPros Dataflow Manager Chosen for Multi-Study Collaboration at FUJIFILM Medical Systems, USA
October 8th 2008PharmaPros, a technical consulting and solutions provider has announced that FUJIFILM Medical Systems USA, a provider of diagnostic imaging products and network systems, has selected the company?s Dataflow Manager solution, and study support services to assist with Fujifilm clinical studies.
Eastern European Agencies Challenge European Medicines Regulatory Network Design
October 7th 2008The contributions Eastern and Central European Member States make to the European Medicines Regulatory Network (EMRN) was the topic of the first session of the Fifth Annual TOPRA Annual Symposium in Budapest.
Pharsight and InforSense Establish Strategic Partnership
October 7th 2008Pharsight Corporation, a provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and InforSense Ltd., aprovider of next-generation business and scientific intelligence tools, announced that they have signed an agreement for InforSense to distribute Pharsight products in China through its Shanghai based subsidiary.
Medicines Regulators on Both Sides of the Atlantic Confirm Commitment to Cooperation on Medicines
October 7th 2008The European Commission (EC), the European Medicines Agency (EMEA) and the United States Food and Drug Administration (FDA) have affirmed their commitment to regulatory cooperation and to intensifying their interactions in several new areas.